Welcome to the MDS 2023 Congress Calendar

The MDS landscape has seen major changes in the past 12 months, bringing exciting prospects for how we view this heterogeneous and dynamic disease but also opening questions for clinicians. What impact do the revised disease classifications have on daily clinical practice? Is blast count still a crucial diagnostic parameter? How can the IPSS-M risk stratification and broad molecular panels be integrated into routine workup? How is the frontline treatment of MDS likely to change in the next 1 to 2 years? Hear global experts discuss the latest guidance and data in the field of higher-risk MDS, stay at the forefront of trending topics, and take the opportunity to ask the experts your own questions during this interactive and educational symposium. We look forward to welcoming you in Marseille to this AbbVie-sponsored symposium, during the 17th International Congress on Myelodysplastic Syndromes (MDS 2023).